Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology
 Disease Category: Stem Cell Transplant
Location: United States, CA

Trial Information

Key Adverse Events after Hematopoietic Cell Transplantation (HCT)

You have been asked to participate in this research study because you have undergone a hematopoietic stem cell transplant (HCT) at the City of Hope and were diagnosed with (a) certain complication(s) after your transplant or because you are part of a control group. For this study, the control group is a group of patients who do not have certain complication(s) but who have had the same type of transplant, length of time since HCT, and race/ethnicity as a patient who has been diagnosed with (a) complication(s). The goals of this study are to look at how certain complications, such as diabetes, heart conditions, lung conditions, stroke, bone problems, hormonal imbalances, and second cancers develop and to see if certain individuals, treatment(s), or genes (the physical unit that carries characteristics from parent to child) are related to an increased risk of getting such complication(s). Your participation in this study is expected to last 20-30 minutes.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.